Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down 4% year-over-year.
Net income attributable to Gilead was $1 billion, or $0.80 per share, compared to $19 million, or $0.02 per share, last year. Adjusted EPS amounted to $1.37.
For the full year of 2023, the company expects adjusted EPS of $6.60-7.00.
Prior performance
Most Popular
Earnings Preview: Best Buy set for modest Q3 gains amid cautious outlook
Best Buy Co., Inc. (NYSE: BBY) is navigating a challenging retail backdrop, marked by cautious consumer spending and tariff-related cost pressure. The consumer electronics retailer's upcoming earnings report is expected
J.M. Smucker (SJM) anticipated to report mixed results for Q2 2026
Shares of The J.M. Smucker Co. (NYSE: SJM) stayed red on Monday. The stock has dropped 3% in the past three months. The branded foods company is scheduled to report
Intuit (INTU) set to report Q1 FY26 results. Here’s what to expect
Intuit Inc. (NASDAQ: INTU) is preparing to report results for the first three months of fiscal 2026, amid expectations for a double-digit increase in revenues and adjusted earnings. While the
